CRDL
Cardiol Therapeutics Inc. Class A Common Shares
Biological Products, (No Diagnostic Substances)
Best Pharmaceutical Stocks 2026 →
CRDL Stock Analysis: Buy, Sell, or Hold?
$1.04
+0.03 (+2.97%)
▲
5d:
+12.25%
30d:
-8.77%
90d:
-42.22%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (95%)
Quality Score
53/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.03 – $1.23
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.2x
Next 12M consensus est.
Wall Street Target
$8.38
+706.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.92 / $1.17
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: CRDL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When CRDL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRDL is currently trading at $1.04, which is considered slightly low relative to its 30-day fair value range of $1.03 to $1.23.
Technical Outlook: Technically, CRDL is in a downtrend. Immediate support is located at $0.92, while resistance sits at $1.17.
Market Sentiment: CRDL scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.38 (+706.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRDL is in a downtrend. Immediate support is located at $0.92, while resistance sits at $1.17.
Market Sentiment: CRDL scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.38 (+706.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.03 -
$1.23
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$1.03 -
$1.23
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.92
Resistance Level
$1.17
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 706.2% below Wall St target ($8.38)
- BULLISH: Bottoming setup score 60/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-3.18
Wall Street Target
$8.38
(+706.2%)
Share CRDL Analysis
Share this live CRDL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRDL)
Neutral
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Cardiol Therapeutics announces an at-the-market offering program with Jefferies LLC for the sale of up to US$75 million of common shares.
Key Retail Themes:
Financial flexibility
Potential for FDA approval and commercialization
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRDL Research Pages
